OmniActive’s OmniLean salacia extract has received self-affirmed GRAS (Generally Recognised as Safe) notification by an expert panel who evaluated the ingredient in accordance with stringent US Food and Drug Administration (FDA) safety criteria.
“OmniLean is a novel, differentiated ingredient with huge opportunity derived from its formula flexibility and versatility in the metabolic health, weight management and satiety categories,” said Lynda M. Doyle, Sr VP of Global Marketing, OmniActive.
“OmniLean comes backed by OmniActive’s robust clinical programme and GRAS self-affirmation, which positions it as a unique, safe and effective ingredient.”
OmniLean, The Metabolic Synergizer, helps to support metabolic health and was recently shown to reduce post-prandial blood glucose and insulin in a human clinical trial in healthy individuals.
Made from salacia, a genus of woody climbers and well known for its traditional use as a medicinal food supplement for various health benefits, OmniLean was developed as a fully traceable extract that supports multiple facets of weight management and metabolic health.
OmniLean is a free-flowing powder that can be used in tablets, capsules, powders and bars for tremendous formulation flexibility.